Stockreport

Taiho Pharmaceutical Exercises Option for an Exclusive License to Casdatifan in Japan and Certain Territories in Asia [Yahoo! Finance]

Arcus Biosciences, Inc.  (RCUS) 
Last arcus biosciences, inc. earnings: 3/5 04:10 pm Check Earnings Report
PDF Biosciences, Inc. (NYSE:RCUS, "Arcus") announced that Taiho exercised its option to develop and, if approved, commercialize casdatifan (International Nonproprietary Name [Read more]